Your browser doesn't support javascript.
loading
Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition).
Zhang, Zhiyi; Huang, Cibo; Jiang, Quan; Zheng, Yi; Liu, Yi; Liu, Shengyun; Chen, Yingjuan; Mei, Yifang; Ding, Changhai; Chen, Min; Gu, Xin; Xing, Dan; Gao, Min; He, Lan; Ye, Zhizhong; Wu, Lijun; Xu, Jianhua; Yang, Pinting; Zhang, Xuewu; Zhang, Yue; Chen, Jinwei; Lin, Jin; Zhao, Like; Li, Mengtao; Yang, Wanling; Zhou, Yixin; Jiang, Qing; Chu, Cong-Qiu; Chen, Yaolong; Zhang, Weiya; Tsai, Wei-Chung; Lei, Guanghua; He, Dongyi; Liu, Wei; Fang, Yongfei; Wu, Darong; Lin, Jianhao; Wei, Cheng-Chung; Lin, Hsiao-Yi; Zeng, Xiaofeng.
Afiliação
  • Zhang Z; Department of Rheumatology and Immunology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Huang C; Department of Rheumatology and Immunology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Jiang Q; Department of Rheumatism, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Zheng Y; Department of Rheumatology, Beijing Chaoyang Hospital Affiliated to Capital University of Medical Sciences, Beijing, China.
  • Liu Y; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
  • Liu S; Department of Rheumatology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Chen Y; Department of Rheumatology and Immunology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Mei Y; Department of Rheumatology and Immunology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Ding C; University of Tasmania, Tasmania, Australia.
  • Chen M; Department of Radiology, Beijing Hospital, National Center of Gerontology, Beijing, China.
  • Gu X; Department of Rehabilitaion Medicine, Beijing Hospital, National Center of Gerontology, Beijing, China.
  • Xing D; Department of Orthopaedics, Peking University People's Hospital, Beijing, China.
  • Gao M; Department of Rheumatology and Immunology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • He L; Department of Rheumatology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Ye Z; Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, China.
  • Wu L; Department of Rheumatology and Immunology, the People's Hospital of the Xinjiang Uygur Autonomous Region, Urumqi, China.
  • Xu J; Department of Rheumatology and Immunology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Yang P; Department of Rheumatic Immunology, the First Affiliated Hospital of China Medical University, Shenyang, China.
  • Zhang X; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Zhang Y; Department of Rheumatology and Immunology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Chen J; Department of Rheumatology, Second Xiangya Hospital, Central South University, Changsha, China.
  • Lin J; Department of Rheumatology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  • Zhao L; Department of Rheumatology and Immunology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Li M; Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
  • Yang W; Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China.
  • Zhou Y; Department of Orthopedics, Beijing Jishuitan Hospital, Beijing, China.
  • Jiang Q; Department of Sports Medicine and Adult Reconstructive Surgery, Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, China.
  • Chu CQ; Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University and VA Portland Health Care System, Portland, OR, USA.
  • Chen Y; Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, WHO Collaborating Centre for Guideline Implementation and Knowledge Translation, Lanzhou, China.
  • Zhang W; Academic Rheumatology, Clinical Sciences Building, University of Nottingham, City Hospital, Nottingham, UK.
  • Tsai WC; Department of Internal Medicine, Kaohsiung Medical College, Kaohsiung.
  • Lei G; Department of Orthopedic, Xiangya Hospital, Central South University, Changsha, China.
  • He D; Department of Arthrology, Guanghua Integrative Medicine Hospital, Shanghai, China.
  • Liu W; Department of Rheumatology and Immunology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Fang Y; Department of Rheumatology and Immunology, Southwest Hospital, Army Medical University, Chongqing, China.
  • Wu D; Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, The Second Clinical School of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Lin J; Department of Orthopedics, Peking University People's Hospital, Beijing, China.
  • Wei CC; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Chung Shan Medical University Hospital, Taichung.
  • Lin HY; Veterans General Hospital, Taipei and National Yang-Ming Medical University, Taipei.
  • Zeng X; Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Ann Transl Med ; 8(19): 1213, 2020 Oct.
Article em En | MEDLINE | ID: mdl-33178745
ABSTRACT
Osteoarthritis (OA) is a degenerative disease of middle-aged and elderly people, contributed a higher burden of disease in China and the world. In 2017, under the support of the Rheumatology and Immunology Expert Committee of the Cross-Strait Medical and Health Exchange Association. The objective was to develop an evidence-based diagnosis and treatment guideline for OA in China based on emerging new evidence. The guideline was registered at International Practice Guidelines Registry Platform (IPGRP-2018CN028). The grading of recommendations assessment, development and evaluation (GRADE) approach was used to rate the quality of evidence and the strength of recommendations, and the RIGHT (Reporting Items for Practice Guidelines in Healthcare) checklist was followed to report the guideline. The guideline provides recommendations for the OA diagnosis, disease risks monitoring and evaluate, treatment purpose and physical, medical and surgical interventions. This guideline is intended to serve as a tool for Chinese clinicians for the best decisions-making on diagnosis and treatment of OA.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Idioma: En Revista: Ann Transl Med Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Idioma: En Revista: Ann Transl Med Ano de publicação: 2020 Tipo de documento: Article